Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (241-250 of 6,083) with videos related to

Pageof 609
Sort By:
The Prostate|December 16, 2003
Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasiaFen Wang, Kerstin McKeehan, Chundong Yu, et al.
The Prostate|December 16, 2003
Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axisJ Rubin, L W K Chung, X Fan, et al.
The Prostate|January 27, 2004
Phase I/II clinical trials of carbon ion therapy for prostate cancerKoichiro Akakura, Hirohiko Tsujii, Shinroku Morita, et al.
The Prostate|September 16, 2004
Trefoil factor 3 is overexpressed in human prostate cancerIsla P Garraway, David Seligson, Jonathan Said, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
The Prostate|September 25, 2004
Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancerPäivi Härkönen, Atte P Kyllönen, Stig Nordling, et al.
The Prostate|September 25, 2004
Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrPD W Burton, J Geller, M Yang, et al.
The Prostate|September 25, 2004
Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivoJodie Palmer, Matthias Ernst, Annet Hammacher, et al.
The Prostate|September 25, 2004
Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPHRosebud O Roberts, Erik J Bergstralh, Sara A Farmer, et al.
The Prostate|September 25, 2004
Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell linesMurielle Mimeault, Nathalie Jouy, Patrick Depreux, et al.
Pageof 609

Showing results (241-250 of 6,083) with videos related to

Sort By:
Pageof 609
The Prostate|December 16, 2003
Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasiaFen Wang, Kerstin McKeehan, Chundong Yu, et al.
The Prostate|December 16, 2003
Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axisJ Rubin, L W K Chung, X Fan, et al.
The Prostate|January 27, 2004
Phase I/II clinical trials of carbon ion therapy for prostate cancerKoichiro Akakura, Hirohiko Tsujii, Shinroku Morita, et al.
The Prostate|September 16, 2004
Trefoil factor 3 is overexpressed in human prostate cancerIsla P Garraway, David Seligson, Jonathan Said, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
The Prostate|September 25, 2004
Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancerPäivi Härkönen, Atte P Kyllönen, Stig Nordling, et al.
The Prostate|September 25, 2004
Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrPD W Burton, J Geller, M Yang, et al.
The Prostate|September 25, 2004
Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivoJodie Palmer, Matthias Ernst, Annet Hammacher, et al.
The Prostate|September 25, 2004
Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPHRosebud O Roberts, Erik J Bergstralh, Sara A Farmer, et al.
The Prostate|September 25, 2004
Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell linesMurielle Mimeault, Nathalie Jouy, Patrick Depreux, et al.
Pageof 609